WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007010356) PROCESS FOR THE PREPARATION OF SULFONAMIDE DERIVATIVES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/010356    International Application No.:    PCT/IB2006/001958
Publication Date: 25.01.2007 International Filing Date: 10.07.2006
IPC:
C07C 303/40 (2006.01), C07D 209/04 (2006.01), C07D 303/36 (2006.01), C07C 237/20 (2006.01), C07C 51/09 (2006.01), C07C 57/34 (2006.01), C07C 311/48 (2006.01), C07C 311/08 (2006.01)
Applicants: PFIZER LIMITED [GB/GB]; Ramsgate Road, Sandwich, Kent CT13 9NJ (GB) (For All Designated States Except US).
GLADWELL, Iain, Robert [GB/GB]; (GB) (For US Only).
DE KONING, Pieter, David [NL/GB]; (GB) (For US Only).
MOSES, Ian, Brian [GB/GB]; (GB) (For US Only).
PETTMAN, Alan, John [GB/GB]; (GB) (For US Only).
THOMSON, Nicholas, Murray [GB/GB]; (GB) (For US Only)
Inventors: GLADWELL, Iain, Robert; (GB).
DE KONING, Pieter, David; (GB).
MOSES, Ian, Brian; (GB).
PETTMAN, Alan, John; (GB).
THOMSON, Nicholas, Murray; (GB)
Agent: DROUIN, Stéphane; Pfizer Research and Development, Ramsgate Road, Sandwich, Kent CT13 9NJ (GB)
Priority Data:
60/700,098 18.07.2005 US
Title (EN) PROCESS FOR THE PREPARATION OF SULFONAMIDE DERIVATIVES
(FR) PROCEDE POUR LA PREPARATION DE DERIVES DE SULFONAMIDE
Abstract: front page image
(EN)The invention relates to a process for the preparation of compounds of formula (I) wherein Q1 is a group selected from formulae (II) & (III) and a group *-NR6 -Q2-A or, if appropriate, their pharmaceutically acceptable salts and/or isomers, tautomers, solvates or isotopic variations thereof, as well as intermediates used in said process.
(FR)L'invention concerne un procédé pour la préparation de composés de formule (I) dans laquelle Q1 représente un groupe sélectionné parmi les groupes de formules (II) et (III) et un groupe *-NR6 -Q2-A ou, si nécessaire, leurs sels et/ou isomères, tautomères, solvates acceptables sur le plan pharmaceutique ou variations isotopiques de ceux-ci, ainsi que des intermédiaires utilisés dans ledit procédé.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)